Recon: Novartis loses patent appeal for MS drug Gilenya; European Commission investigates Vifor for anticompetitive practices

• 'Put up or shut up': Biden, Dems have one last chance to resurrect drug pricing reforms ahead of elections (Endpoints)
• Medicare could have saved billions on drugs if it paid what Mark Cuban charges at his new pharmacy (STAT) (Endpoints)
• Merck touts new data for breakthrough pneumococcal vaccine as it heads to PhIII trials (Endpoints)
• U.S. Supreme Court rebuffs UnitedHealth Group challenge on Medicare overpayments (Reuters)
• Novartis loses in patent appeal over multiple sclerosis drug (Reuters)
• U.S. COVID vaccine rollout for young children will pick up pace (Reuters)

• AstraZeneca, Ionis eye U.S. approval after positive trial data (Reuters) (Endpoints)
• PTC’s Duchenne muscular dystrophy drug achieves study goal, potentially confirming European approval (STAT)
• European Commission investigates Vifor for ‘disparaging’ its only rival in iron deficiency market (STAT) (EC)
• European researchers seek greater stake in drug development in bid to improve access (STAT)
• Biocon denies allegations it bribed Indian regulator to waive diabetes drug's pivotal trial  (Fierce) (Times of India)
• Some Omicron sub-variants escaping antibodies from Sinopharm shot, Chinese study says (Reuters)

• Center for Breakthrough Medicines plans for an even larger dive into cell therapy manufacturing (Endpoints)
• Rare disease outfit Acer fumbles at FDA, receiving CRL due to lack of inspection readiness at packaging manufacturer (Endpoints)
• 15 leaders giving voice and visibility to the LGBTQ community in biopharma (Endpoints)
• Carbon Biosciences emerges with a new viral vector to shake up the cystic fibrosis gene therapy field (Endpoints)

• U.S. factories pop up to make medical gloves, spurred by pandemic (Reuters)
• Devicemaker MicroTransponder raises $53M and more digital health fundings (MobiHealthNews)
• Cardio Catch-Up: Updates From B-Secur, Egnite, Vektor, And Other Under-The-Radar Companies (MedtechInsight)
• How a sports apparel company helped one Virginia health system pivot to reusable gowns (MedtechDive)